NGF and Mental deterioration: Initially targeting cholinergic pathways in the basal forebrain, a 2001 small trial in eight patients of intraparenchymally injected fibroblasts expressing nerve growth factor (NGF) slowed cognitive decline and improved FDG PET measures [7].